Clinical Trials Browser

Phase 3 × Hyperparathyroidism, Primary × evocalcet × Clear all

NCT03280264 2021-05-27

Phase 3 Study of KHK7580 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Primary Hyperparathyroidism

Phase 3 Completed

18 enrolled 13 charts

Parathyroid Neoplasms, Hyperparathyroidism, Primary